Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
cancer therapeutics Market Research Reports
cancer therapeutics Market Research Reports
| Title | published | price | |
|---|---|---|---|
Relapsed Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... iew of the Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Relapsed Chronic Lymphocytic Leukemia (CLL), complete with analysis by Sta......" | 02-May-2022 | $2500 | |
Metastatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... Cancer pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Metastatic Bile Duct Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route......" | 02-May-2022 | $2000 | |
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... MoA, RoA, Molecule Type and Key Players provides an overview of the B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) pipeline landscape.
The report provides comprehensive information on the therapeutics under dev......" | 02-May-2022 | $2500 | |
Papillary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for Papillary Tumor, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The ......" | 02-May-2022 | $2000 | |
Paranasal Sinus And Nasal Cavity Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... he Paranasal Sinus And Nasal Cavity Cancer pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Paranasal Sinus And Nasal Cavity Cancer, complete with analysis by Stage of Developmen......" | 02-May-2022 | $2000 | |
Pituitary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for Pituitary Tumor, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The ......" | 02-May-2022 | $2000 | |
Refractory Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... oma pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Refractory Medulloblastoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of ......" | 02-May-2022 | $2000 | |
Epithelial Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Epithelial Ovarian Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Admi......" | 02-May-2022 | $2500 | |
Salivary Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ndscape.
The report provides comprehensive information on the therapeutics under development for Salivary Gland Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA)......" | 02-May-2022 | $2000 | |
Hormone Sensitive Breast Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... tive Breast Cancer pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Hormone Sensitive Breast Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Act......" | 02-May-2022 | $2000 | |
| | |||